When Hugo Aerts, PhD, started asking colleagues whether the thymus could play a role in determining which patients with cancer would respond to immunotherapy about 4 years ago, the responses were overwhelmingly dismissive.“It’s irrelevant,” they told him. “[The thymus is] important in kids. Afterwards, it doesn’t matter.”“Are you sure?” Aerts, director of the Artificial Intelligence in Medicine Program at Mass General Brigham, asked. “We have the data. Let’s investigate this.”The data are showing thymus health could have wide-ranging implications for patients with and without cancer.Aerts and
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Immunotherapy increases risk for major cardiovascular events | 0 | 10.61 | 23-09-2026 |
| 2 | Patients with lung malignancy have more airway microplastics | 0 | 8.14 | 25-09-2026 |
| 3 | ‘Persistent gaps’ in lung cancer screening communication | 0 | 8.49 | 22-09-2026 |
| 4 | Insurance hinders home-injection program of breast cancer therapy | 0 | 10.14 | 24-09-2026 |
| 5 | EGFR variant raises lung cancer risk 60-fold in never smokers | 0 | 9.76 | 22-09-2026 |
| 6 | FDA panel supports multicancer early detection test | 0 | 9.97 | 24-09-2026 |
| 7 | My Metastatic Breast Cancer Diagnosis Inspired Me to Get Outside Even on Bad Days | 0 | 12.09 | 01-09-2026 |
| 8 | GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan | 0 | 14.91 | 23-03-2026 |
| 9 | GSK’227, a B7-H3-targeted antibody-drug conjugate, granted Orphan Drug Designation in small-cell lung cancer by the US FDA | 0 | 16.47 | 10-12-2025 |
| 10 | GSK presents latest respiratory research to advance patient care at ATS 2026 | 0 | 14.1 | 06-05-2026 |